Abstract: Disclosed herein are surfactant peptide nanostructures wherein the peptides have repeating hydrophobic amino acids in an integer equal to or less than four. The peptide nanostructures are useful for therapeutic applications, including for delivery of drugs and siRNA.

Abstract: Disclosed herein are surfactant peptide nanostructures wherein the peptides have repeating hydrophobic amino acids in an integer equal to or less than four. The peptide nanostructures are useful for therapeutic applications, including for delivery of drugs and siRNA.

Abstract: Disclosed herein are surfactant peptide nanostructures wherein the peptides have repeating hydrophobic amino acids in an integer equal to or less than four. The peptide nanostructures are useful for therapeutic applications, including for delivery of drugs and siRNA.

Abstract: The present invention relates to a triblock copolymer having a polyethylene glycol-poly(D,L-lactide)-polyethylene glycol skeleton.

Abstract: Compositions, methods and delivery devices (e.g., pre-filled syringes) for controlling bleeding during surgical procedures are provided, wherein the compositions are characterized as having an aqueous formulation that is capable of adopting a gelled state upon contact with bodily fluids and/or blood of a patient (i.e., physiological conditions).

Abstract: Disclosed herein are surfactant peptide nanostructures wherein the peptides have repeating hydrophobic amino acids in an integer equal to or less than four. The peptide nanostructures are useful for therapeutic applications, including for delivery of drugs and siRNA.

Abstract: The present invention relates to a triblock copolymer having a polyethylene glycol-poly(D,L-lactide)-polyethylene glycol skeleton.

Abstract: Compositions, methods and delivery devices (e.g., pre-filled syringes) for controlling bleeding during surgical procedures are provided, wherein the compositions are characterized as having an aqueous formulation that is capable of adopting a gelled state upon contact with bodily fluids and/or blood of a patient (i.e., physiological conditions).

Abstract: Provided is a mucosa-elevating agent containing 0.1% to 1.0% of a peptide, wherein the peptide is an amphipathic protein having 8 to 200 amino acid residues in which hydrophilic amino acids and hydrophobic amino acids are alternately bonded, and is a self-assembling peptide that exhibits a ? structure in an aqueous solution at physiological pH and/or in the presence of cations.

Abstract: A gas turbine combustor is provides with a stabilizer at a downstream side of a premixing device for premixing and supplying fuel and air into a combustion chamber. The stabilizer has a cylindrical part extending axially from an upstream end thereof to a downstream end and a stabilizing part at the downstream end of the cylindrical part for stabilizing a flame, and the stabilizer is mounted on an inside of the combustor by a plurality of members arranged annularly and secured to the inside of the combustor at their ends, each of the members having a part slidably inserted in an opening of the cylindrical part so as to restrict the stabilizer to move axially while allowing deformation of the stabilizer and another part supporting the upstream end of the cylindrical part so as to restrict radial movement of the stabilizer.

Abstract: A reflection type projection screen is constituted as follows. Provided in order on a light absorbing layer 5, which is a dark plastic sheet or a solid print of a dark ink, are a fibrous sheet 4 of glass fibers, a white, opaque base material sheet 3made with a plastic sheet, and a light diffusing layer 2 of a translucent plastic into which a lustrous pigment or calcite powder is incorporated. An emboss 9 is formed on the outer surface of the light diffusing layer 1. It is preferable that a reflection layer 2 printed with an ink containing a lustrous pigment or calcite powder is provided below the light diffusing layer 1. Light absorbing stripes 11 are provided each at a position corresponding to a concave portion 9a of the emboss 9 on the surface of the base material sheet 3 adjoining the light diffusing layer 1. A production process and a production apparatus of a reflection type screen, which can efficiently produce reflection type screens with the emboss are also disclosed.

Abstract: A coating composition for a cast-coated paper which principally comprises a pigment and an adhesive and in which the adhesive is composed of (A) a rubber latex having an average particle size of 0.1 to 0.3 micron and (B) a rubber latex or an acrylic emulsion having an average particle size of 0.5 to 1.5 micron and the sum of the solid content of the components (A) and (B) is in the range of 9 to 30 parts by weight per 100 parts by weight of the pigment is herein provided. The coating composition may further contain casein as a binder. In addition, inorganic compounds selected from NaCl, Na.sub.2 SO.sub.4, ZnO and MgO and organic acid salts selected from formates or acetates of Ca, Zn, Mg may be added to the coating composition as coagulants. The use of the aforesaid coating composition makes it possible to produce cast-coated paper having excellent permeability, gloss and surface strength at a high speed.

Abstract: A reagent for blood analysis comprises, as a lysing reagent for leukocyte count, tetradecyltrimethylammonium bromide and/or hexadecyltrimethylammonium chloride, dodecyltrimethylammonium chloride, and citric acid. This reagent is characterized by showing three-peaks fractionation of leukocytes in measuring by means of an automatic blood-analysis instrument. The lysing reagent is used together with a diluent comprising boric acid buffer solution, ethylenediaminetetraacetic acid and (2-pyridylthio-1-oxide) sodium.

Abstract: A reagent for blood analysis comprises, as a lysing reagent for leukocyte count, tetradecyltrimethylammonium bromide and/or hexadecyltrimethylammonium chloride, dodecyltrimethylammonium chloride, and citric acid. This reagent is characterized by showing three-peaks fractionation of leukocytes in measuring by means of an automatic blood-analysis instrument. The lysing reagent is used together with a diluent comprising boric acid buffer solution, ethylenediaminetetraacetic acid and (2-pyridylthio-1-oxide) sodium.

Abstract: Disclosed is a method of heat-treating a pipe in which cooling water is passed through the pipe while the pipe is heated from the outer side thereof, so as to create a temperature differential between the outer and the inner sides of the pipe, so that the inner side of the pipe may be tension-yielded or the outer side of the pipe may be compression-yielded, thereby to generate a compressive residual stress and a tensile residual stress at the inner and the outer sides of the pipe, respectively.